FDA Clearance Tracker · P190002-S020
Saluda Medical Evoke SCS System
Last checked: Nov 20, 2026Latest source record: Mar 25, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 25, 2024
Approved
Time to decision
179 days
Received Sep 28, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P190002-S020
- Device name
- Saluda Medical Evoke SCS System
- Applicant
- Saluda Medical Pty, Ltd.
- Applicant location
- Atarmon
- Received
- Sep 28, 2023
- Decided
- Mar 25, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P190002
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for modifications to the Surgical Guide to allow the use of the commercially available Medtronic Injex Anchors (models 97791 and 97792) with the Evoke SCS System
Source documents
Other decisions for Saluda Medical Pty, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Saluda Medical Evoke® SCS SystemPMA supplement
P190002-S019 · Decided Mar 20, 2024 · 180 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.